This guide explores the different sources of funding available to biotech startups and their relative merits, and how you should best utilize that funding at each stage of your research.
BioSpace presents the NextGen Bio “Class of 2020,” a list of up-and-coming life sciences companies in North America that launched no earlier than mid-2018.
Companies continue to announce advancements in artificial intelligence programming as they harness the power of AI and machine learning to aid in drug discovery and development.
Pfizer is ending five preclinical programs in the biosimilar area and cutting 150 positions in Lake Forest, Illinois and in Chennai, India.
What do Microsoft, Aetna, Twitter, IBM, Ogilvy Consulting, Biogen and dozens of healthcare startups have in common? All appear in discussions about issues at the nexus of healthcare and technology in Icons.Health, a new video series produced by AbelsonTaylor.
BioSpace presented the NextGen Bio “Class of 2019,” a list of 20 up-and-coming life science companies in North America that launched no earlier than 2017. According to BioSpace, the companies are already making an enormous impact on the industry and will continue to do so into the future.
Here is a look at BioSpace’s top 10 stories of 2018.
For the 11th year, Med Ad News selected new Pharmaceutical Marketing Ventures to Watch that could change the way pharmaceutical products are marketed and sold.
In seeking innovative players that could change pharma and healthcare, Med Ad News found the developer of an app that helps people determine what illnesses are in their neighborhoods; the creator of a wearable injector that allows patients on biologics to receive these drugs outside the clinic; and a designer of a deep learning network aimed at giving pharma and healthcare companies a handle on their data.
Axovant Sciences announced that the biotech start-up licensed exclusive worldwide rights to OXB-102, now dubbed AXO-Lenti-PD, from Oxford BioMedica.